These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

261 related items for PubMed ID: 16200349

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Induction of human papilloma virus E6/E7-specific cytotoxic T-lymphocyte activity in immune-tolerant, E6/E7-transgenic mice.
    Riezebos-Brilman A, Regts J, Freyschmidt EJ, Dontje B, Wilschut J, Daemen T.
    Gene Ther; 2005 Sep; 12(18):1410-4. PubMed ID: 15843807
    [Abstract] [Full Text] [Related]

  • 25. Development of an adenoviral vaccine against E6 and E7 oncoproteins to prevent growth of human papillomavirus-positive cancer.
    Lee DW, Anderson ME, Wu S, Lee JH.
    Arch Otolaryngol Head Neck Surg; 2008 Dec; 134(12):1316-23. PubMed ID: 19075129
    [Abstract] [Full Text] [Related]

  • 26. Antigen-specific CD8+ T lymphocytes generated from a DNA vaccine control tumors through the Fas-FasL pathway.
    Cheng WF, Lee CN, Chang MC, Su YN, Chen CA, Hsieh CY.
    Mol Ther; 2005 Nov; 12(5):960-8. PubMed ID: 15979942
    [Abstract] [Full Text] [Related]

  • 27. Recombinant DNA vaccines protect against tumors that are resistant to recombinant vaccinia vaccines containing the same gene.
    Chen CH, Wang TL, Ji H, Hung CF, Pardoll DM, Cheng WF, Ling M, Wu TC.
    Gene Ther; 2001 Jan; 8(2):128-38. PubMed ID: 11313782
    [Abstract] [Full Text] [Related]

  • 28. An improved rearranged Human Papillomavirus Type 16 E7 DNA vaccine candidate (HPV-16 E7SH) induces an E7 wildtype-specific T cell response.
    Ohlschläger P, Pes M, Osen W, Dürst M, Schneider A, Gissmann L, Kaufmann AM.
    Vaccine; 2006 Apr 05; 24(15):2880-93. PubMed ID: 16472545
    [Abstract] [Full Text] [Related]

  • 29. Modified HPV16 E7/HSP70 DNA vaccine with high safety and enhanced cellular immunity represses murine lung metastatic tumors with downregulated expression of MHC class I molecules.
    Li H, Ou X, Xiong J.
    Gynecol Oncol; 2007 Mar 05; 104(3):564-71. PubMed ID: 17081598
    [Abstract] [Full Text] [Related]

  • 30. Enhancement of suicidal DNA vaccine potency by delaying suicidal DNA-induced cell death.
    Kim TW, Hung CF, Juang J, He L, Hardwick JM, Wu TC.
    Gene Ther; 2004 Feb 05; 11(3):336-42. PubMed ID: 14737094
    [Abstract] [Full Text] [Related]

  • 31. Vaccination with a DNA vaccine based on human PSCA and HSP70 adjuvant enhances the antigen-specific CD8+ T-cell response and inhibits the PSCA+ tumors growth in mice.
    Zhang X, Yu C, Zhao J, Fu L, Yi S, Liu S, Yu T, Chen W.
    J Gene Med; 2007 Aug 05; 9(8):715-26. PubMed ID: 17595048
    [Abstract] [Full Text] [Related]

  • 32. Enhanced immunogenicity of HPV 16 E7 fusion proteins in DNA vaccination.
    Michel N, Osen W, Gissmann L, Schumacher TN, Zentgraf H, Müller M.
    Virology; 2002 Mar 01; 294(1):47-59. PubMed ID: 11886264
    [Abstract] [Full Text] [Related]

  • 33. Enhancement of dendritic cell-based vaccine potency by anti-apoptotic siRNAs targeting key pro-apoptotic proteins in cytotoxic CD8(+) T cell-mediated cell death.
    Kim JH, Kang TH, Noh KH, Bae HC, Kim SH, Yoo YD, Seong SY, Kim TW.
    Immunol Lett; 2009 Jan 29; 122(1):58-67. PubMed ID: 19135479
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. A combination of DNA vaccines targeting human papillomavirus type 16 E6 and E7 generates potent antitumor effects.
    Peng S, Tomson TT, Trimble C, He L, Hung CF, Wu TC.
    Gene Ther; 2006 Feb 29; 13(3):257-65. PubMed ID: 16177818
    [Abstract] [Full Text] [Related]

  • 36. A novel therapeutic fusion protein vaccine by two different families of heat shock proteins linked with HPV16 E7 generates potent antitumor immunity and antiangiogenesis.
    Liu B, Ye D, Song X, Zhao X, Yi L, Song J, Zhang Z, Zhao Q.
    Vaccine; 2008 Mar 04; 26(10):1387-96. PubMed ID: 18272260
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Induction of specific CD8+ T-lymphocyte responses using a human papillomavirus-16 E6/E7 fusion protein and autologous dendritic cells.
    Murakami M, Gurski KJ, Marincola FM, Ackland J, Steller MA.
    Cancer Res; 1999 Mar 15; 59(6):1184-7. PubMed ID: 10096544
    [Abstract] [Full Text] [Related]

  • 40. Maintenance of CD8 effector T cells by CD4 helper T cells eradicates growing tumors and promotes long-term tumor immunity.
    Lin CT, Chang TC, Shaw SW, Cheng PJ, Huang CT, Chao A, Soong YK, Lai CH.
    Vaccine; 2006 Sep 11; 24(37-39):6199-207. PubMed ID: 16824651
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.